| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |